- Home
- PMNT vs PYPD Comparison
PMNT vs PYPD Comparison
Compare PMNT & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMNT
- PYPD
- Stock Information
- Founded
- PMNT 1984
- PYPD 2008
- Country
- PMNT United Kingdom
- PYPD Israel
- Employees
- PMNT N/A
- PYPD N/A
- Industry
- PMNT
- PYPD Medical/Dental Instruments
- Sector
- PMNT
- PYPD Health Care
- Exchange
- PMNT NYSE
- PYPD Nasdaq
- Market Cap
- PMNT 14.6M
- PYPD 16.5M
- IPO Year
- PMNT 2024
- PYPD 2020
- Fundamental
- Price
- PMNT $1.00
- PYPD $2.93
- Analyst Decision
- PMNT Strong Buy
- PYPD Strong Buy
- Analyst Count
- PMNT 1
- PYPD 2
- Target Price
- PMNT $6.00
- PYPD $12.00
- AVG Volume (30 Days)
- PMNT 79.7K
- PYPD 28.7K
- Earning Date
- PMNT 11-14-2024
- PYPD 02-12-2025
- Dividend Yield
- PMNT N/A
- PYPD N/A
- EPS Growth
- PMNT N/A
- PYPD N/A
- EPS
- PMNT N/A
- PYPD N/A
- Revenue
- PMNT $22,375,000.00
- PYPD N/A
- Revenue This Year
- PMNT $3.91
- PYPD N/A
- Revenue Next Year
- PMNT $29.32
- PYPD N/A
- P/E Ratio
- PMNT N/A
- PYPD N/A
- Revenue Growth
- PMNT N/A
- PYPD N/A
- 52 Week Low
- PMNT $0.70
- PYPD $2.37
- 52 Week High
- PMNT $6.05
- PYPD $9.20
- Technical
- Relative Strength Index (RSI)
- PMNT N/A
- PYPD 33.37
- Support Level
- PMNT N/A
- PYPD $2.37
- Resistance Level
- PMNT N/A
- PYPD $3.13
- Average True Range (ATR)
- PMNT 0.00
- PYPD 0.24
- MACD
- PMNT 0.00
- PYPD -0.06
- Stochastic Oscillator
- PMNT 0.00
- PYPD 19.30
About PMNT PERFECT MOMENT LTD
Perfect Moment Ltd is a company which is a luxury lifestyle brand that combines fashion and technical performance for its ranges of skiwear, outerwear, swimwear, and activewear. It operates at the intersection of luxury fashion and multi-channel commerce. Although the Company is organized fundamentally as one business segment which is product sales, the Company's revenues are primarily split between three geographic areas which are the U. S., Europe, and the UK.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.